Australian Clinical Labs LtdASX: ACL

Notification of buy-back - ACL

· Issued by Australian Clinical Labs Ltd

Filed with ASX · · 5 pages · English

Summary by 6ix AI

Australian Clinical Labs Ltd has announced a buy-back of its ordinary fully paid securities on the market. The maximum number of securities proposed to be bought back is specified, although the exact price is not yet known. The buy-back is set to commence in mid-September and is expected to conclude in mid-September of the following year. The company retains the right to suspend or terminate the buy-back based on various factors.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Australian Clinical Labs Ltd on 6ix

In the deck

Story so far

Earlier from Australian Clinical Labs

Later from Australian Clinical Labs

All Australian Clinical Labs news releases